Determining the causal attribution of human papillomavirus (HPV) genotypes to cervical
disease is important to estimate the effect of HPV vaccination and to establish a type …

Background Prospective data on the risks of cervical precancer associated with specific
human papillomavirus (HPV) genotypes are limited Methods In 5060 women participating in …

Background Limited data are available describing human papillomavirus (HPV) genotype
distributions in cervical cancer in the United States. Such studies are needed to predict how …

Persistent cervical infections with carcinogenic human papillomaviruses (HPV) cause
virtually all cervical cancer. Cytologic abnormalities are the manifestations of HPV infections …

The age-specific occurrence of cervical cancer related to human papillomavirus (HPV)
genotypes HPV16 and HPV18, the two targeted by current HPV vaccines, is not well …

Prevalence of different HPV genotypes is changing after HPV vaccination. The associated
risks are needed for optimizing cervical cancer screening. To estimate HPV type-specific …

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …

Only a subset of cervical precursor lesions progress to cervical cancer and because of the
lack of the predictive markers, it cannot be ascertained which lesions will progress or not. To …

Prevalence of 27 human papillomavirus (HPV) genotypes was assessed in 1,331 women in
three clinical settings: Family planning clinic (low‐risk HIV−, n= 202, 21.3% HPV+) …

Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …